Original Query: ALL
Previous Study | Return to List | Next Study

TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove) (TE-Prove)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01242696
Recruitment Status : Completed
First Posted : November 17, 2010
Last Update Posted : February 3, 2017
Pharmaceutical Research Associates
Information provided by (Responsible Party):
Boston Scientific Corporation